Intrinsic Value of S&P & Nasdaq Contact Us

ADC Therapeutics S.A. ADCT NYSE

NYSE • Healthcare • Biotechnology • CH • USD

SharesGrow Score
39/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.50
+94.3%

Stock Statistics — ADCT

ADC Therapeutics S.A. (ADCT) has a market capitalization of $490.39M and trades at $3.86. The 52-week range is 1.05-4.98.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.4, Earnings Per Share (EPS) of $-1.12, annual revenue of $81.36M.

The stock has a beta of 1.95, operates in the Healthcare sector.

Trading Data
Current Price$3.86
52-Week Range1.05-4.98
Volume537.44K
Avg Volume (30D)816.29K
Market Cap$490.39M
Beta (1Y)1.95
Company
IPO Date2020-05-18
Employees263
CEOAmeet Mallik
CountryCH
ExchangeNYSE
CurrencyUSD
ISINCH0499880968
CUSIPH0036K147
Income (Latest Year)
Revenue$81.36M
Gross Profit$73.68M
EBITDA$-106.5M
Operating Income$-108.38M
Net Income$-142.62M
EPS$-1.12
EPS Diluted$-1.12
Shares Outstanding$127.07M
Balance Sheet (Latest Year)
Total Assets$323.15M
Current Assets$306.34M
Cash & ST Investments$261.34M
Total Liabilities$508.98M
Total Debt$439.01M
Net Debt$177.67M
Total Equity$-185.83M
Debt / Equity-2.36
Valuation Ratios
P/E Ratio-3.4
P/S Ratio6.03
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message